EastHORN is pleased to announce its participation at this year’s Partnerships in Clinical Trials Europe, event held on 27th – 29th November 2018 | CCIB Convention Centre, Barcelona.
As usual, Partnerships in Clinical Trials Europe will focus on networking, exchange, and collaboration for the future of clinical trials. Apart from the 50+ hours of discussion, this year’s PCT will bring focus on new topics:
- Regulatory challenges for 2018 – The Clinical Trial Regulation, ICH GCP E6R2 and GDPR
- Impact of M&A’s of CRO’s
- Patient focused dialogue
- Innovation through technology
Iain Gordon, Chief Business Officer, EastHORN Clinical Services
Initially with big pharma before transitioning into contract research at the turn of the millennium, Iain Gordon has been involved in the pharmaceutical industry for more than 20 years. Since the first tentative steps into Poland and Hungary in the 90’s he has enjoyed and been a key part of the spectacular growth in clinical services across Europe and beyond. Senior management roles as European Head and Global VP of Business Development have enabled Iain to be at the leading edge of business and corporate development within the global CRO industry.
Iain is based at EastHORN’s offices in the UK.
Mark Anderson, Senior Director Business Development, EastHORN Clinical Services
For the past 21 years Mark has worked closely with biotech and pharmaceutical clients around the globe helping them to successfully plan and execute their clinical trials. Mark started his career in Clinical Research in 1997, firstly as a CRA and then as a Project Manager before transitioning into Business Development in 2003. Although located in Europe for the majority of his career (now based in Dublin, Ireland), Mark also spent 5 years in Boston between 2005-2010 and is looking forward to seeing old friends at DIA as well as making new ones.